<?xml version='1.0' encoding='UTF-8'?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/" xmlns:blogger="http://schemas.google.com/blogger/2008" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr="http://purl.org/syndication/thread/1.0" version="2.0"><channel><atom:id>tag:blogger.com,1999:blog-510410376109552611</atom:id><lastBuildDate>Sun, 08 Sep 2024 19:01:42 +0000</lastBuildDate><category>Pharma Financial Forum</category><category>Pharma Finance</category><category>pharma dollars and sense</category><category>IFRS</category><category>Converting to IFRS</category><category>FASB</category><category>Accounting</category><category>Accounting rule changes</category><category>Accounting rules</category><category>Bloomberg</category><category>CFO</category><category>GAAP</category><category>Pharma Accounting</category><category>US GAAP</category><category>Canadian Accounting</category><category>Credit crisis</category><category>Financial accounting</category><category>Healthcare Investment Transactions Summit</category><category>IRS</category><category>Impact Assesment</category><category>International Accounting Standards Board</category><category>James Kroeker</category><category>Mary Schapiro</category><category>Medicaid Drug Rebate Program</category><category>Reuters</category><category>SEC Chairman</category><category>SEC Chief Accountant</category><category>Taxes</category><category>The Journal of Accountancy</category><category>WebCPA</category><category>balance sheets</category><category>complimentary webinar</category><category>healthcare industry</category><category>AICPA Trends Report</category><category>Accountants</category><category>Accountin gmasters</category><category>Accounting Charge</category><category>Accounting Principles</category><category>Accounting Standards</category><category>Accounting degrees</category><category>Accounting interpretations</category><category>Accounting methods</category><category>Accounting obligations</category><category>Accounting social network</category><category>Accounting system change</category><category>Ambient</category><category>American International Group</category><category>Americas Health Insuranc Plans</category><category>Audit</category><category>Audit Integrity</category><category>Bank of America</category><category>Bankruptcy</category><category>Banks</category><category>BizTimes</category><category>Bob Hertz</category><category>Brazil</category><category>Budget cuts</category><category>Business cell phones</category><category>CFERF</category><category>CPAs knowledge of IFRS</category><category>California Progress Report</category><category>Carbon Accounting</category><category>Cashflow</category><category>Cell phone taxes</category><category>Changing accounting rules in a recession</category><category>Chief Accountant</category><category>Chief Accounting Officer</category><category>China Daily</category><category>Climate change accounting</category><category>Computer World</category><category>Consumer Financial Protection Agency</category><category>Contingent liabilities</category><category>Cost of adopting IFRS</category><category>Deloitte Touche Tohmatsu</category><category>Deloitte and Touche</category><category>Dennis Howlett</category><category>Doug Shulman</category><category>Early adopters</category><category>Earnings stripping</category><category>Earnst and Young</category><category>Equipment leasing</category><category>Eric Hespenheide</category><category>European Federation of Accountancy Bodies</category><category>FAS 157</category><category>FEI Canada</category><category>Face to face social networks</category><category>Fair Market Value Rules</category><category>Fair Value Accounting</category><category>Federal regulators</category><category>Fiduciary accounting</category><category>Fierce Healthcare</category><category>Financial Crisis Advisory Board</category><category>Financial health</category><category>Forbes</category><category>GASP</category><category>Germany</category><category>Global Accounting Alliance</category><category>Global recession</category><category>Global wealth investment</category><category>Glogbal accounting standards</category><category>Governmental Accouting Standards Board</category><category>Governmental accounting</category><category>Grant Thorton study</category><category>Happy Holidays from Pharma Dollars and Sense</category><category>Hits</category><category>IASB</category><category>IFRS Adoption</category><category>IFRS Roadmap</category><category>IFRS USA</category><category>IFRS accounting sstem</category><category>IFRS accounting system</category><category>IT changes</category><category>Income taxes</category><category>Increasing savings</category><category>Indiana State Government</category><category>Insurance contracts</category><category>International Accounting</category><category>International accounting matters</category><category>Investment management firm</category><category>Investor relations</category><category>JRG VEntures</category><category>Jaguar</category><category>Joint Ventures</category><category>KPMG</category><category>Land Rover</category><category>Lawsuit accounting</category><category>Lawsuit disclosures and accounting</category><category>Lawyers</category><category>Lease accounting</category><category>Lenders</category><category>Loan accounting</category><category>Malcolm McKay</category><category>Mark Olson</category><category>Mark to Market</category><category>Market prices accounting</category><category>Market to market accounting</category><category>Maurice Greenberg</category><category>National Income accounting</category><category>Neil Cotty</category><category>Obama</category><category>Off balance vehicle sheets</category><category>Operating cash flow</category><category>PJ Patel</category><category>Patient volumes</category><category>Paul Cherry</category><category>PennLive</category><category>Pension Accounting</category><category>Pension plans</category><category>Pensions and Investments</category><category>Pharma Taxes</category><category>Plant leasing</category><category>Pricewaterhouse Coopes</category><category>Private Insurance</category><category>Private accounting</category><category>Professional Accounting Practice Issues</category><category>Property leasing</category><category>Public Company Accounting Oversight Board</category><category>Public accounting</category><category>Public companies coverting to IFRS</category><category>Reducing costs</category><category>Regulatory requirements</category><category>Research and development</category><category>Retirement Plans</category><category>SEC Division of Corporate Finance</category><category>San Diego</category><category>Second quarter 2009 returns</category><category>Securities and Exchange Commission</category><category>Sir David Tweedie</category><category>Social Network</category><category>State Accounting records</category><category>Tata Motors</category><category>Tax compliance</category><category>Tenent Healthcare Corporation</category><category>The Economist</category><category>Topic 820</category><category>Training for new accounting system</category><category>Transparent Accounting System</category><category>US Audit Industry</category><category>Universal Accounting Standards</category><category>Valor Economico</category><category>Valuation Research Corp</category><category>Value of assets</category><category>Vancouver Sun</category><category>Wall Street Journal</category><category>Wayne Carnall</category><category>Yahoo</category><category>Zenei Cortez</category><category>ar</category><category>doctors</category><category>drug companies</category><category>finance</category><category>gorman health group</category><category>healthcare news</category><category>medicare congress</category><category>medicare news</category><category>new york</category><category>new york times</category><category>pharma</category><category>pharma news</category><category>principle based accounting</category><category>sarah rubenstein</category><category>tax barriers overseas</category><category>vermont government</category><category>webinar news</category><category>welcome</category><title>Pharma Dollars and Sense</title><description>A look at accounting and finance issues, techniques, and challenges within the Pharmaceutical and BioTech industries.</description><link>http://pharmadollarsandsense.blogspot.com/</link><managingEditor>noreply@blogger.com (Anonymous)</managingEditor><generator>Blogger</generator><openSearch:totalResults>53</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-5763791205733591277</guid><pubDate>Fri, 25 Dec 2009 11:00:00 +0000</pubDate><atom:updated>2009-12-25T06:00:02.780-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Happy Holidays from Pharma Dollars and Sense</category><title>Happy Holidays from Pharma Dollars and Sense</title><atom:summary type="text">We&#39;re taking some much needed time off from our coverage of Pharma to celebrate the season with our loved ones. We want to sincerely thank you for your readership, your comments and your participation.  Here are our highest rated articles from 2009:  Pharma Dollars and Sense: Will principle based accounting improve financial reporting?Pharma Dollars and Sense: IFRS versus US GAAPPharma Dollars </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/12/happy-holidays-from-pharma-dollars-and.html</link><author>noreply@blogger.com (Unknown)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-2183563060673073529</guid><pubDate>Mon, 14 Dec 2009 15:43:00 +0000</pubDate><atom:updated>2009-12-14T10:48:18.122-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">complimentary webinar</category><category domain="http://www.blogger.com/atom/ns#">gorman health group</category><category domain="http://www.blogger.com/atom/ns#">Medicaid Drug Rebate Program</category><category domain="http://www.blogger.com/atom/ns#">medicare congress</category><category domain="http://www.blogger.com/atom/ns#">medicare news</category><title>Complimentary Webinar: Assessing the Impact of Healthcare Reform on the Business of Medicare: An Interview with Gorman Health Group</title><atom:summary type="text">Space is limited.Reserve your Webinar seat now at:https://www1.gotomeeting.com/register/504426600Mention Priority code: P1507W1BLOGJohn Gorman, CEO, Gorman Health Group, along with Jean LeMasurier, Senior Vice President, Public Policy, Gorman Health Group will examine the current state of US healthcare reform, and its short and long term impact on Medicare plans including the financial, </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/12/complimentary-webinar-assessing-impact_14.html</link><author>noreply@blogger.com (Unknown)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-8423164321587837561</guid><pubDate>Wed, 09 Dec 2009 15:18:00 +0000</pubDate><atom:updated>2009-12-09T10:25:25.770-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Ambient</category><category domain="http://www.blogger.com/atom/ns#">healthcare industry</category><category domain="http://www.blogger.com/atom/ns#">Healthcare Investment Transactions Summit</category><category domain="http://www.blogger.com/atom/ns#">Hits</category><category domain="http://www.blogger.com/atom/ns#">JRG VEntures</category><title>Healthcare Investment &amp; Transaction Summit, New York City - Early Bird Ends This Friday, December 11</title><atom:summary type="text">IIR’s Healthcare Investment &amp;amp; Transaction Summit (HITS), now taking place on January 28-29, 2010 in New York City, is the deal-making industry event of the year! Join us today and be one of the many to benefit from the year’s most prestigious healthcare deal-making event. HITS brings together the industry’s financial giants, with buyers and sellers, and the brokers who connect them and the </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/12/healthcare-investment-transaction.html</link><author>noreply@blogger.com (Unknown)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-408901955509547372</guid><pubDate>Tue, 08 Dec 2009 16:09:00 +0000</pubDate><atom:updated>2009-12-08T11:11:42.769-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">complimentary webinar</category><category domain="http://www.blogger.com/atom/ns#">healthcare industry</category><category domain="http://www.blogger.com/atom/ns#">healthcare news</category><category domain="http://www.blogger.com/atom/ns#">pharma news</category><category domain="http://www.blogger.com/atom/ns#">webinar news</category><title>Complimentary Webinar: Assessing the Impact of Healthcare Reform on the Business of Medicare: An Interview with Gorman Health Group</title><atom:summary type="text">December 15, 20092-3PM ESTSpace is limited.Reserve your Webinar seat now at:https://www1.gotomeeting.com/register/504426600Mention Priority Code: P1507W1BLOGJohn Gorman, CEO, Gorman Health Group, along with Jean LeMasurier, Senior Vice President, Public Policy, Gorman Health Group will examine the current state of US healthcare reform, and its short and long term impact on Medicare plans </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/12/complimentary-webinar-assessing-impact.html</link><author>noreply@blogger.com (Unknown)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgvLz9JZxga9PnYt8yyUEjt-et1pU4Hs0rlWy_7MRbumQMEwVq4UM4PTq7kFy54pEhLmi3wDcjYKwoVeF9WaPS76qeIoFXh9vR-FxQzO8mr33-UCUaQlOb_2S6L4f6_y0gAYWGFjCP0vC_K/s72-c/jean_09.jpg" height="72" width="72"/><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-5003242446710613359</guid><pubDate>Mon, 07 Dec 2009 16:59:00 +0000</pubDate><atom:updated>2009-12-07T12:12:19.011-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Americas Health Insuranc Plans</category><category domain="http://www.blogger.com/atom/ns#">California Progress Report</category><category domain="http://www.blogger.com/atom/ns#">Healthcare Investment Transactions Summit</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Private Insurance</category><category domain="http://www.blogger.com/atom/ns#">Zenei Cortez</category><title>Health care reform: Private Insurers paying for federal lobbying</title><atom:summary type="text">A recent article written by Zenei Cortez at the California Progress Report looks at how the current finances in the health care industry are being geared towards federal lobbying.  In fact, the article state that the nation&#39;s top 13 private health insurers and their trade group, America&#39;s Health Insurance Plans (AHIP) spent nearly $23  million  in federal lobbying to tilt reform in their </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/12/health-care-reform-private-insurers.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-1334542166431425880</guid><pubDate>Tue, 15 Sep 2009 18:28:00 +0000</pubDate><atom:updated>2009-09-15T14:32:51.887-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Federal regulators</category><category domain="http://www.blogger.com/atom/ns#">Global recession</category><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">International Accounting Standards Board</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><title>Adopting IFRS Key to global financial success</title><atom:summary type="text">According to the Associated Press, federal regulators stated Monday that it&#39;s critical for the United States along with other countries to adopt one international accounting standard.  By all countries having the same policies, we would better avoid another economic crisis.  Both those on Wall Street and in the Accounting industry agree with this statement.  US companies have the option to begin </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/09/adopting-ifrs-key-to-global-financial.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7288936642934576658</guid><pubDate>Fri, 04 Sep 2009 14:43:00 +0000</pubDate><atom:updated>2009-09-04T10:47:16.046-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">FAS 157</category><category domain="http://www.blogger.com/atom/ns#">Mark to Market</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Topic 820</category><category domain="http://www.blogger.com/atom/ns#">Wall Street Journal</category><title>Name Change for FAS 157</title><atom:summary type="text">The Wall Street Journal Blog recently wrote about the name change for FAS 157.  It will now be known as Topic 820.  This rule currently requires companies mark their assets to market every quarter.  With the old rule, the assets were held at cost.  Read more about the name and rule change here.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/09/name-change-for-fas-157.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-8551593417154199798</guid><pubDate>Tue, 01 Sep 2009 20:03:00 +0000</pubDate><atom:updated>2009-09-01T16:08:04.201-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accounting system change</category><category domain="http://www.blogger.com/atom/ns#">Indiana State Government</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Training for new accounting system</category><title>Indiana Government converting to centralized accounting system</title><atom:summary type="text">According to Fox 28 of South Bend, Indiana, the Hoosier government will be converting to one single accounting system.  The complete transition will take place by September 16.  This has been in the works for years, and over 3,000 state employees have been trained on the new system.  Read the full article here.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/09/indiana-government-converting-to.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-8831067284642050083</guid><pubDate>Thu, 27 Aug 2009 14:16:00 +0000</pubDate><atom:updated>2009-08-27T10:20:23.726-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">James Kroeker</category><category domain="http://www.blogger.com/atom/ns#">Mary Schapiro</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">SEC Chief Accountant</category><category domain="http://www.blogger.com/atom/ns#">Securities and Exchange Commission</category><title>What does Kroeker’s appointment mean for IFRS?</title><atom:summary type="text">On Tuesday, the Securities and Exchange Commission appointed James L. Kroeker the permanent chief accountant at the agency.  Many in the industry thought SEC’s Mary Schapiro would select someone with a little more resistance to IFRS.  How will the industry respond to a big four Chief Accountant?  And most importantly, what does Kroeker’s appointment mean for the timelines surrounding IFRS </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/what-does-kroekers-appointment-mean-for.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7813821023529317733</guid><pubDate>Wed, 26 Aug 2009 16:02:00 +0000</pubDate><atom:updated>2009-08-26T12:07:39.229-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accounting interpretations</category><category domain="http://www.blogger.com/atom/ns#">Chief Accountant</category><category domain="http://www.blogger.com/atom/ns#">International accounting matters</category><category domain="http://www.blogger.com/atom/ns#">James Kroeker</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Professional Accounting Practice Issues</category><category domain="http://www.blogger.com/atom/ns#">SEC Chief Accountant</category><title>James L. Kroeker becomes SEC&#39;s permanent cheif accountant</title><atom:summary type="text">The Wall Street Journal stated that James L. Kroeker will become the permanent chief accountant for the Securities and Exchange Commission.  He has been serving as the chief accountant since January.  He will be overseeing accounting interpretations, professional practice issues and international accounting matters.How do you think Kroeker&#39;s new position will affect the United States and it&#39;s </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/james-l-kroeker-becomes-secs-permanent.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-3780108578179553203</guid><pubDate>Mon, 24 Aug 2009 18:42:00 +0000</pubDate><atom:updated>2009-08-24T14:44:51.223-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Converting to IFRS</category><category domain="http://www.blogger.com/atom/ns#">GAAP</category><category domain="http://www.blogger.com/atom/ns#">IT changes</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">The Journal of Accountancy</category><title>Controlling your risk when converting to IFRS</title><atom:summary type="text">The Journal Of Accountancy recently published a post that looks at how companies can take precautions when it comes to converting from GAAP to IFRS.  One of the key areas that will be affected during the conversion will be IT, as many of the systems will be changing due to the new accounting methods.  Read the full article here.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/controlling-your-risk-when-converting.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-1922453500359699579</guid><pubDate>Thu, 20 Aug 2009 21:24:00 +0000</pubDate><atom:updated>2009-08-20T17:30:21.487-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">CFO</category><category domain="http://www.blogger.com/atom/ns#">FASB</category><category domain="http://www.blogger.com/atom/ns#">Lawsuit accounting</category><category domain="http://www.blogger.com/atom/ns#">Lawsuit disclosures and accounting</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><title>FASB&#39;s changes on disclosing private information</title><atom:summary type="text">According to CFO, there is debate as to how companies are handling lawsuits and their accounting rules and disclosures.  Under the new rules of FASB, companies would not have to disclose any information that they feel is prejudicial or confidential.  This would include not disclosing any information about the money they pay to investors to settle disagreements. Last September, when the board </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/fasbs-changes-on-disclosing-private.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-2385565812206053259</guid><pubDate>Wed, 19 Aug 2009 16:25:00 +0000</pubDate><atom:updated>2009-08-19T12:33:55.403-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Credit crisis</category><category domain="http://www.blogger.com/atom/ns#">Glogbal accounting standards</category><category domain="http://www.blogger.com/atom/ns#">IFRS Adoption</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Reuters</category><category domain="http://www.blogger.com/atom/ns#">Transparent Accounting System</category><title>Adopting IFRS slowing</title><atom:summary type="text">In an article recently at Reuters India, they look at how the current global economy is just one of the latest factors holding up the adoption of IFRS globally.  Due to the credit crisis, many countries have seen the need to adopt a more consistent and transparent accounting system.  However, with the US failing to provide a date as to when they&#39;ll be adopting the system.  The G20 Finance </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/adopting-ifrs-slowing.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>1</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7019213770250179287</guid><pubDate>Mon, 17 Aug 2009 19:04:00 +0000</pubDate><atom:updated>2009-08-17T15:45:53.641-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accounting</category><category domain="http://www.blogger.com/atom/ns#">Accounting rule changes</category><category domain="http://www.blogger.com/atom/ns#">Bloomberg</category><category domain="http://www.blogger.com/atom/ns#">Fair Market Value Rules</category><category domain="http://www.blogger.com/atom/ns#">FASB</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><title>Fair market value rules may expand</title><atom:summary type="text">According to Bloomberg, last week, FASB decided to consider expanding fair market value rules.  Accountants could end up expanding mark-to-market across all financial assets.  Read the full article here.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/fair-market-value-rules-may-expand.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-735856939592169510</guid><pubDate>Tue, 11 Aug 2009 20:51:00 +0000</pubDate><atom:updated>2009-08-11T16:54:32.777-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accountants</category><category domain="http://www.blogger.com/atom/ns#">Accounting social network</category><category domain="http://www.blogger.com/atom/ns#">Face to face social networks</category><category domain="http://www.blogger.com/atom/ns#">Lawyers</category><category domain="http://www.blogger.com/atom/ns#">Lenders</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Social Network</category><title>New network for accountants</title><atom:summary type="text">A new social network for accountants has been launched.  Hub Street is a social network that brings together accountants, lawyers, and lenders to create connections in the industries.  It also has a unique aspect for social networks.Fox Coaching Associates CEO Nancy Fox explains, “Let’s face it – it’s not what you know, but who you know.  Unlike most online and face-to-face networks, HubStreet </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/new-network-for-accountants.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-5294563270853661791</guid><pubDate>Mon, 10 Aug 2009 17:50:00 +0000</pubDate><atom:updated>2009-08-10T13:54:42.399-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accounting Charge</category><category domain="http://www.blogger.com/atom/ns#">American International Group</category><category domain="http://www.blogger.com/atom/ns#">Maurice Greenberg</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><title>Former AIG Executive settling accounting charge</title><atom:summary type="text">Maurice &quot;Hank&quot; Greenberg, Former American International Group Chief Executive, will pay $15 million to settle an accounting charge. According to the article,Greenberg and Smith were responsible for &quot;material misstatements&quot; that helped AIG create the false impression that the insurer had consistently met or exceeded key earnings and growth targets, the SEC claimed.Read the full article here.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/former-aig-executive-settling.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-8653056964136794060</guid><pubDate>Wed, 05 Aug 2009 18:30:00 +0000</pubDate><atom:updated>2009-08-05T14:41:40.058-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Cost of adopting IFRS</category><category domain="http://www.blogger.com/atom/ns#">Early adopters</category><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">SEC Chairman</category><category domain="http://www.blogger.com/atom/ns#">US GAAP</category><title>How are you handling the transition to IFRS standards?</title><atom:summary type="text">The SEC estimates the transition from US GAAP to IFRS will cost each early adopter $32 million over the first three years. Although the convergence for large accelerated manufacturers doesn’t occur until 2014, you can start reducing your $32 million spend by planning for a smooth, timely transition today.• Have you planned for the cost associated with transitioning to IFRS?• Do you understand the</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/how-are-you-handling-transition-to-ifrs.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-6956460442333272834</guid><pubDate>Wed, 05 Aug 2009 15:53:00 +0000</pubDate><atom:updated>2009-08-05T12:02:19.871-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Bob Hertz</category><category domain="http://www.blogger.com/atom/ns#">European Federation of Accountancy Bodies</category><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">IFRS Roadmap</category><category domain="http://www.blogger.com/atom/ns#">Mary Schapiro</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">SEC Chairman</category><category domain="http://www.blogger.com/atom/ns#">Sir David Tweedie</category><category domain="http://www.blogger.com/atom/ns#">US GAAP</category><title>Tweedie encourages US to join IFRS</title><atom:summary type="text">At WebCPA, they divulge that Sir David Tweedie has encouraged the United States to come up with an adoption plan for IFRS.  Although Tweeide has and FASB Chairman Bob Hertz have worked closely together to weave US GAAP into IFRS, the new leader of the SEC, Mary Schapiro has not said whether or not she has approved of the latest model of the roadmap to adoption. During the American Accounting </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/tweedie-encourages-us-to-join-ifrs.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-2349342941124202815</guid><pubDate>Mon, 03 Aug 2009 19:13:00 +0000</pubDate><atom:updated>2009-08-03T15:18:37.541-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Converting to IFRS</category><category domain="http://www.blogger.com/atom/ns#">CPAs knowledge of IFRS</category><category domain="http://www.blogger.com/atom/ns#">GAAP</category><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><title>CPAs knowledge in IFRS and GAAP</title><atom:summary type="text">The IFRS blog recently asked if your CPA was bilingual.  Although the United States has not yet fully committed to adopting IFRS, many other countries throughout the world have begun to take the steps to adopt this new worldwide accounting system.  EM sees a new state of accounting in 2012, that where either the US has adopted IFRS or an accounting world where IFRS and GAAP coexist.  So, he </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/08/cpas-knowledge-in-ifrs-and-gaap.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-739314784952075429</guid><pubDate>Thu, 30 Jul 2009 20:39:00 +0000</pubDate><atom:updated>2009-07-30T16:44:13.941-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Fierce Healthcare</category><category domain="http://www.blogger.com/atom/ns#">Patient volumes</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Reducing costs</category><category domain="http://www.blogger.com/atom/ns#">Second quarter 2009 returns</category><category domain="http://www.blogger.com/atom/ns#">Tenent Healthcare Corporation</category><title>Tenent Healthcare Corp improves returns</title><atom:summary type="text">According to Fierce Healthcare, Tenent Healthcare Corporation has posted better returns than previously expected for the second quarter.  By holding down costs, offsetting growing bad debts, and lowering patient volumes they managed to push revenue up 4.5% and improve their free cash flow.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/07/tenent-healthcare-corp-improves-returns.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7659727541888724550</guid><pubDate>Wed, 29 Jul 2009 16:33:00 +0000</pubDate><atom:updated>2009-07-29T12:37:02.278-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accountin gmasters</category><category domain="http://www.blogger.com/atom/ns#">Accounting degrees</category><category domain="http://www.blogger.com/atom/ns#">AICPA Trends Report</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">The Journal of Accountancy</category><title>Number of accounting degrees is up</title><atom:summary type="text">According to an article at The Journal of Accountancy, 66,000 Masters or Bachelors degrees were awarded to accounting graduates in the 2007-2008 school year.  This is up 3.5% from the 2006-2007 academic year.  Read some of the other findings in the AICPA 2009 Trends Report here.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/07/number-of-accounting-degrees-is-up.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-3963845549508490526</guid><pubDate>Tue, 28 Jul 2009 20:31:00 +0000</pubDate><atom:updated>2009-07-28T16:36:38.318-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accounting rule changes</category><category domain="http://www.blogger.com/atom/ns#">Accounting rules</category><category domain="http://www.blogger.com/atom/ns#">Credit crisis</category><category domain="http://www.blogger.com/atom/ns#">Financial Crisis Advisory Board</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><title>Current financial crisis not caused by change in accounting rules</title><atom:summary type="text">According to the AP, The Financial Crisis Advisory Group has stated that changes in accounting rules did not cause the most recent credit crisis.  They did state that there are weaknesses in the application rules that may reduce the credibility in the financial reporting.  To see all of their current views, please read the article here.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/07/current-financial-crisis-not-caused-by.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7669892896395544498</guid><pubDate>Mon, 27 Jul 2009 18:40:00 +0000</pubDate><atom:updated>2009-07-27T14:45:11.178-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accounting rule changes</category><category domain="http://www.blogger.com/atom/ns#">Bloomberg</category><category domain="http://www.blogger.com/atom/ns#">Jaguar</category><category domain="http://www.blogger.com/atom/ns#">Land Rover</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Tata Motors</category><title>Tata Motors profits rise after change in accounting rules</title><atom:summary type="text">According to Bloomberg, Tata Motors, who won Jaguar and Land Rover, saw an increase in profit after the Indian government changed accounting rules.  They allowed companies to alter provsions for mark-to-market losses in foreign currency loans.  This resulted in a profit rise of 58%.  Read more here.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/07/tata-motors-profits-rise-after-change.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-4246856374983994330</guid><pubDate>Fri, 24 Jul 2009 19:04:00 +0000</pubDate><atom:updated>2009-07-24T15:09:28.622-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Bank of America</category><category domain="http://www.blogger.com/atom/ns#">Chief Accounting Officer</category><category domain="http://www.blogger.com/atom/ns#">Global wealth investment</category><category domain="http://www.blogger.com/atom/ns#">Investment management firm</category><category domain="http://www.blogger.com/atom/ns#">Neil Cotty</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><title>Bank of America has new Chief Accounting Officer</title><atom:summary type="text">Yesterday, Neil Cotty was named the new Chief Accounting Officer at Bank of America.  His previous position was chief financial officer at a global wealth and investment management firm.  Read more about their new selection here.</atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/07/bank-of-america-has-new-chief.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-2013889046448832458</guid><pubDate>Wed, 22 Jul 2009 17:50:00 +0000</pubDate><atom:updated>2009-07-22T13:56:23.717-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">balance sheets</category><category domain="http://www.blogger.com/atom/ns#">CFO</category><category domain="http://www.blogger.com/atom/ns#">Equipment leasing</category><category domain="http://www.blogger.com/atom/ns#">FASB</category><category domain="http://www.blogger.com/atom/ns#">Lease accounting</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Plant leasing</category><category domain="http://www.blogger.com/atom/ns#">Property leasing</category><title>Accouting for leases may change soon</title><atom:summary type="text">An article at CFO updates us on the current progress of an accounting rule that could change the way companies account for leases.  Any company that leases plants, property or equipment would be responsible for FASB predicts this new rule will be in place by 2011.Under the current rule, companies distinguish between capital lease obligations, which appear on the balance sheet, and operating </atom:summary><link>http://pharmadollarsandsense.blogspot.com/2009/07/accouting-for-leases-may-change-soon.html</link><author>noreply@blogger.com (Anonymous)</author><thr:total>0</thr:total></item></channel></rss>